원문 보기
What's up guys? . Mr. Peter Lynch says that it is better to find a stock which is available very cheaply. It is better for you to find these stocks which are a little expensive but will give you a lot of growth. This means that it is very important that you chase the growth of the stock and not cheap stocks and this is the biggest mistake we make.
No, the most we buy are those cheap stocks which are of ₹2, ₹5 which are not doing anything, where there is no business but we have to buy them. Whenever I recommend to any of my friends that brother, buy this stock worth ₹2000, they are so scared of buying a stock worth ₹5000. He says friend, no no friend, it is very expensive and nothing can be done with ₹00 ₹000.
The important thing is that the stock is not cheaper by Rs 2000, 5000 or 10000. That stock is cheaper than its business and its valuation. You may be getting a stock for ₹00 but it is getting cheap because according to its valuation, that stock should be more expensive. So you think that it would be good if you buy any stock below ₹100.
I do n't know how many times it will increase. But a stock of Rs 10,000 can be multiplied by 1 lakh times, it can also be worth Rs 1 lakh. Why can't it happen? Do n't we have stock of MRF tyres? Do n't we have that in stock? What was his name who suddenly ran away very fast? Look at the share which was listed recently.
What was his name? Well, that has become the most expensive stock in our stock market, whatever it is, I don't even like its name. So now you see that MRF has reached us up to ₹1.5 lakh. The stock had reached Rs 1.5 lakh. Now you think about these huge and expensive stocks. Wouldn't those stocks be worth ₹1.5 lakh and you think that stocks are not expensive.
There is only one MRF, the stocks are expensive but they are made cheaper by splitting them. It is made cheaper by issuing bonus shares so that everyone can enter it, so that retail investors can participate in it and there is more buying in it. The stock is made cheaper in this way to increase liquidity.
You feel that the stock worth Rs 10,000 is expensive and the one worth Rs 2,000 is cheap. Doesn't happen like this. Right? So that stock worth Rs 10,000 is worth Rs 10,000 because they are not doing a stock split. Bonus shares are not being issued to him. We are not splitting it. That's why it seems expensive to you.
But it is not expensive. Right? It is better that you buy a stock of a good company. Even if it is expensive. Even if it is worth ₹100. I wo n't say it's expensive, even if it costs ₹10,000. It would be better if you buy 100 stocks of some useless company. Even if it is only worth ₹ 10. Right? So, in terms of expensive stock, there should be quality and you should not get cheap stock.
And that's what Peter Lynch says. Peter Lynch says that a company with aggressive growth should be held if it has good growth. Even if it is a little expensive. And we call this Garp Investing. GG ARP GARP Investing means Growth at a Reasonable Price. And this concept of Garf Investing was brought by Mr.
Peter Lynch in his book. Its One Upon a Wall Sweet is a very interesting book. And I started with Learn to One. One Upon Wall Street Sweet mentioned that the GAAR investing method is a more efficient investing method because it gives you stocks to invest in, businesses that are a little expensive, but they are moving towards growth, so they will become more expensive in the future.
It does n't matter, you can sell them at a higher price because they are constantly moving. So, you have to chase growth, not cheap stocks. And when I entered "Growth at a Reasonable Price," I entered it on my screener because I have a paid version of the screener. So, I entered it on the screener and searched for "Gar Growth at a Reasonable Price." If I were to tell you the code I entered, it would be: Market Capitalization should be greater than 5,000, Return on Equity should be more than 5000, Return on Equity should be more than 7000, Sales Growth should be more than 7000, Sales Growth five years should be more than 5000, Profit Growth three years should be more than 7000.
Ratio peg ratio should be more than one so if we add all these things. After doing so much research, when we looked into this, we found many stocks suitable for investing. But I picked out one stock from it, Blue Jet Health. What is BlueJet Health now ? If you see its PE in this, it will appear a little expensive to you.
Has a PE of 31. Growth in butt stocks is very good. I found that interesting. Now let me show you its horoscope. Its market cap is Rs 11,000 crore. 11369 crores. Current price has gone up to ₹128 at 4656. It has fallen to ₹6656. I have already explained the price to earnings ratio of the stock. 31 is the stock's price to earnings.
Book Value 65 Dividend Yield 7.17 Look at ROCE and ROE you see ROCE is 39.8 ROCE 39.8 and ROE is 30.2 right how dangerous ROC ROE. Is this really just a made up ROC ROE? We will see further. Now if we read a little about this company, it is a manufacturer pharmaceutical and health care ingredients and intermediates company and the first manufacturer of saccharin and its salt sweeteners in India.
These are the first manufacturers. What do you say? Manufacturers of saccharin and its salts in India. Right? Now let us move ahead. I do n't go into much detail about this. But now see, we do not have its data for 10 years. It is an industry company and its stock was around Rs 389 in November 2023.
From there it ran and reached 1000 and now it has fallen and is struggling around 656. Right? Now Pro See Company Is Almost That Free Mo Company Is Expected To Give Good Quarter. The company has a good return on equity. We know everything. Right? Now we move on to profit and loss. That is important.
First, we look at profit and loss. Let us see the sales, brother, the growth in the company will be known only when the company will sell the bad goods or not. If we look at the sales, it has decreased from Rs 538 crore in March 2020 to Rs 499 crore in 2021. Then it increased to 683 in 2022, now catch up with the speed from here, 721 in March 2023, 712 in March 2024, now 1030 in March 2025 and what do they say now?
March 2026 has not yet arrived but sales of Rs 1022 crore have already been achieved. If we look at the net profit, it is also continuously increasing. 145 142 182 160 164 305 360 around 359 right so here it is continuously increasing its profits also. Now look at its cash flow, it is a company that consistently manages positive cash flow.
But right now its cash flow has been a bit affected. Last year it was seen to be Rs 241 crore and now for 2025 it is just Rs 25. In 2025 they had a cash flow of Rs 46 crore. Now we move on to promoter holding. If you look at the promoter holding, the promoter's holding has reduced a bit. 86% in the first 2023.
Promoters still hold 79% of the company. Right? FIIs held 2%. DI had 3%. The public held 7%. This is the data for 2023. If we look at the current situation, the public has increased its holding. The holding of FIIs is the same and the holding of FFI has decreased slightly by 1% and the holding of DI is the same.
So basically whatever goods the promoter has sold have been grabbed by the public. So this is the story of Blue Jet. Blue Jet Health Care. So you should try to catch such stocks in which you see growth, in which you see ROC ROE, in which you see PIG, in which you see GARC i.e. growth and reasonable price, if you see growth in the company then you can buy it a little expensive also because if the company is growing then the PE of the company will keep increasing and will keep expanding because I had told you that if you watch the old video of PE ratio, then when the share on earnings increases then the PE will automatically get adjusted, so it is very important to increase the share on earnings.
Right? So I hope you enjoyed this video. Yes like, share and subscribe and I will see you in the next video. Remember one thing, whenever you invest, take your own decision. Do your own research and then take any decision. This is just for your knowledge and in. I will see you in the next video. Bye bye.







Comments 0